Cannabis use and flap reconstruction: A propensity score matched analysis.
Cannabis use and flap reconstruction: A propensity score matched analysis.
复制标题
大麻的使用和皮瓣重建：倾向评分匹配分析。
DOI：
10.1002/micr.31038
复制
发表时间：
2023
期刊：
影响因子：
2.1
通讯作者：
Taub,PeterJ
中科院分区：
文献类型：
--
作者：
Oleru,OlachiO;Seyidova,Nargiz;Mai,Davis;Taub,PeterJ
截至 2022 年 2 月，已有 37 个州和 4 个地区实现医用大麻合法化，其中 21 个州实现娱乐用途大麻合法化。因此，大麻是美国第三大使用最多的娱乐物质，仅次于酒精和烟草，并且大量手术患者是大麻使用者（Karmen Hanson，2022）。重建外科医生应该意识到其潜在的并发症，因为大麻与术后呼吸道并发症、血栓栓塞和败血症有关（Teven & Song，2021）。鉴于大麻对重建结果的潜在影响，本信介绍了一项研究，旨在描述隔离基线大麻使用对皮瓣重建后并发症的影响。2009 年至 2013 年期间查询了纽约州规划和研究合作系统 (SPARCS) 数据库，以确定所有接受皮瓣重建的患者。 SPARCS 是一个全面的全州数据库报告系统，用于跟踪和收集纽约州第 28 条许可医院的所有住院和门诊的去识别化患者特征、诊断、治疗、服务和费用。诊断和程序数据根据国际疾病分类第 9 版临床修订版 (ICD-9-CM)（国际疾病分类，1978 年）进行分类。如果患者年龄超过 18 岁并且具有皮瓣重建的 ICD 代码（86.7、86.70、86.71、86.72、86.73 和 86.74），则患者被纳入。队列是根据是否存在大麻使用基线而创建的。倾向评分匹配用于对患者人口统计、医院参数、合并症和术后结果进行单变量和多变量分析。如果患者同时使用或滥用大麻以外的物质，则被排除在外。显着性设定为α=。 05所有数据准备和分析都是用SAS完成的。
As of February 2022, 37 states and 4 territories have legalized medical marijuana, with 21 states having legalized it for recreational use. As such, cannabis is the third most used recreational substance in the United States, behind alcohol and tobacco, and a significant number of surgery patients are cannabis users (Karmen Hanson, 2022). Reconstructive surgeons should be aware of its potential complications, as cannabis has been linked to postoperative respiratory complications, thromboembolism, and sepsis (Teven & Song, 2021). Given the potential impacts of cannabis on reconstructive outcomes, the present letter describes a study that aims to characterize the effects of isolated baseline cannabis use on complications following flap reconstruction.The New York Statewide Planning and Research Cooperative System (SPARCS) database was queried between 2009 and 2013 to identify all patients who underwent flap reconstruction. SPARCS is a comprehensive, statewide database reporting system that tracks and collects de-identified patient characteristics, diagnoses, treatments, services, and charges for all inpatient and outpatient visits at Article 28 licensed hospitals in New York State. Diagnostic and procedural data are classified according to the International Classification of Diseases, 9th revision, Clinical Modifications (ICD-9-CM)(International Classification of Diseases, 1978). Patients were included if they were over the age of 18 and had ICD codes for flap reconstruction (86.7, 86.70, 86.71, 86.72, 86.73, and 86.74). Cohorts were created based on the presence or absence of baseline cannabis use. Propensity score matching was utilized for univariate and multivariate analysis of patient demographics, hospital-based parameters, comorbidities, and postoperative outcomes. Patients were excluded if they had concurrent substance use or abuse other than cannabis. Significance was set at α=. 05 and all data preparation and analysis was done with SAS.